Strong preclinical data support planned clinical trial initiation in 2026 Oslo, Norway, 16 December 2025– Zelluna (OSE: ZLNA), a company developing off-the-shelf cell therapies for cancer, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback